DOI: 10.1016/0027-5107(95)00251-0 53
GLP-1s have dominated the peptide game and the cultural conversation for the past few years, but Jeffrey Lee, MD, a board-certified plastic surgeon in Boston, notes that there are many others emerging, and they may have a wide range of effects
These options help cash-paying patients, say, in the deductible phase of their insurance, or those who are not insured (either no health insurance at all, or not insured for obesity medicines)
Tchang says, Errors in microdosing could result in overdosing, where you might be exposed to much higher doses than intended. Obesity medicine experts emphasize that any use of lower-than-approved doses should only occur under close medical supervision and with individualized guidance